[] In a recent review, the use of genistein in in vitro and in vivo animal models of cancer reduced the proliferation of mammary gland and prostatic tumors in 74% of animals, and also suppressed tumor cell lines in in vitro models
Tirzepatide is initiated at 2.5 mg subcutaneously once weekly for 4 weeks as a starting dose to improve gastrointestinal tolerability, then gradually titrated every 4 weeks up to a maximum of 15 mg weekly based on therapeutic response and tolerability
Frequently Asked Questions Alcohol use during Mounjaro treatment is not prohibited but discouraged due to: Risk of hypoglycemia Increased gastrointestinal side effects Interference with weight-loss goals Mounjaro clears from the system in 25 days through 5 half-life cycles of 5 days each
At our Auburn clinic, providers review medical history, lab results, and individual health goals before recommending treatment
Bring a small insulated case with a cold pack, along with your prescription label or pharmacy documentation showing it is a compounded medication